Targeting Progress: Patient Perspective on Antibody-Drug Conjugates in Gynecologic Cancer Care
Antibody-drug conjugates (ADCs) are novel therapeutic agents designed to target specific tumor markers with potent anticancer drugs. The Association of Cancer Care Centers (ACCC) is dedicated to providing up-to-date information on ADC treatment management. In this episode, CANCER BUZZ speaks with Nancy Mallett, a patient advocate, to discuss the patient's perspective and experience receiving treatment for gynecologic cancers, particularly with ADCs such as mirvetuximab soravtansine-gynx.
"[Providers] giving me the information and allowing us to decide together, instead of just telling me…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.